Brinzolamide / brimonidine

Details

Files

Generic Name:

Brinzolamide / brimonidine

Project Status:

Complete

Therapeutic Area:

Glaucoma and ocular hypertension

Manufacturer:

Alcon Canada Inc.

Call for patient/clinician input open:

October 1, 2014

Brand Name:

Simbrinza

Project Line:

Reimbursement Review

Project Number:

SR0403-000

Call for patient/clinician input closed:

November 20, 2014

NOC Status at Filing:

Pre NOC

Performance Metric:

Not achieved

Submission Type:

Initial

Indications:

Glaucoma and ocular hypertension

Recommendation Type:

List

Final Recommendation:

June 17, 2015

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Patient Group Input Submissions View PDF

Fixed-Dose Combination Review Report View PDF

Last Updated : November 3, 2014